Trifluorometanosulfonato de 1-etil-3-metil-imidazolio, mínimo 99 %, 100 g, envase de vidrio

3-Aminopyrazine-2-carboxamide, 95.0%, 5g

9-([1,1'-Biphenyl]-4-yl)-9'-phenyl-9H,9'H-3,3'-bicarbazole, 95%, 5g

Ethyl 6-oxooctanoate, 97.0%, 2g

(S)-2-((S)-2-Amino-3-phenylpropanamido)propanoic acid, 95.0%, 5g

(3aS,6R)-8,8-Dimethyl-4,5,6,7-tetrahydro-3H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide, 98.0%, 100g

3-CHLORO-6-METHYL-2-NITROANILINE, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromothiophen-2-yl)propanoic acid, 96.0%, 250mg

3-(4-(Iodomethyl)phenyl)-3-(trifluoromethyl)-3H-diazirine, 97%, 250mg

2-Bromo-5-hydroxypyrazine>95.0%(GC)1g

Quinazoline-2,4-diamine, 95.0%, 5g

3-[(2-aminoethyl)(2-carboxyethyl)amino]propanoic acid dihydrochloride, 98%, 500mg

3-Bromo-2-methoxybenzonitrile, 95.0%, 5g